Apnimed, Inc. (APMD)
Last updated: 2026-11-12 00:26:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Apnimed, Inc. (APMD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $16.68, with a market capitalization of $658.18M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13.88 to $35.29. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$658.18M | |
$15.99 | |
$35.29 | |
$13.88 | |
$15.86 | |
162.12K | |
474.71K | |
-- | |
$35.29 | |
$13.88 | |
-- | |
-- |
Apnimed, Inc. (APMD) After-Hours Stock Price
Apnimed, Inc. (APMD) is trading at $17.25 in after-hours trading as of 2026-11-11 22:49:00, up 8.76% ($1.39) from the regular-session close of $15.86.
After-hours trading shows how investors are pricing APMD after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Apnimed, Inc. (APMD) 7-Day Stock Price Change
Over the past seven days, Apnimed, Inc. (APMD) moved from $15.40 to $16.68, representing a gain of 8.31% ($1.28).
The stock traded between $13.88 and $16.99 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 436.19 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
APMD 52-Week Price Position
Position in Range: 13.1%
APMD is currently trading at $16.68, placing it 13.1% of the way from its 52-week low of $13.88 to its 52-week high of $35.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Apnimed, Inc. (APMD)?
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
Apnimed, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Exchange | NASDAQ |
| Company Website |
How to Buy Apnimed, Inc. (APMD) Stock on MEXC
Eligible investors can buy real shares of Apnimed, Inc. (APMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Apnimed, Inc. (APMD) stock price today?
2.Is APMD stock going up or down today?
3.What is APMD pre-market price?
4.What is APMD after-hours price?
5.Is APMD stock trading now?
6.Where does APMD sit relative to its 52-week high and low?
7.What sector is Apnimed, Inc. in?
8.What is Apnimed, Inc.'s market capitalization and where is it listed?
9.How is APMD valued in terms of P/E ratio and EPS?
10.Does Apnimed, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
APMD Stock Calculator
Estimate the value between APMD shares and USD.
APMD Shares to USD
1.00 APMD shares = 16.68 USD
Calculations are estimates based on the latest available price and are for reference only.




